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ABSTRACT
Objective: To investigate in patients with essential tremor (ET) treated with thalamic/subthalamic
deep brain stimulation (DBS) whether stimulation-induced dysarthria (SID) can be diminished by
individualized current-shaping with interleaving stimulation (cs-ILS) while maintaining tremor sup-
pression (TS).
Methods: Of 26 patients screened, 10 reported SID and were invited for testing. TS was
assessed by the Tremor Rating Scale and kinematic analysis of postural and action tremor. SID
was assessed by phonetic and logopedic means. Additionally, patients rated their dysarthria on
a visual analog scale.
Results: In 6 of the 10 patients with ET, DBS-ON (relative to DBS-OFF) led to SID while tremor
was successfully reduced. When comparing individualized cs-ILS with a non–current-shaped
interleaving stimulation (ILS) in these patients, there was no difference in TS while 4 of the
6 patients showed subjective improvement of speech during cs-ILS. Phonetic analysis (ILS vs
cs-ILS) revealed that during cs-ILS there was a reduction of voicing during the production of
voiceless stop consonants and also a trend toward an improvement in oral diadochokinetic rate,
reflecting less dysarthria. Logopedic rating showed a trend toward deterioration in the diadocho-
kinesis task when comparing ON with OFF but no difference between ILS and cs-ILS.
Conclusion: This is a proof-of-principle evaluation of current-shaping in patients with ET treated
with thalamic/subthalamic DBS and experiencing SID. Data suggest a benefit on SID from individ-
ual shaping of current spread while TS is preserved.
Classification of evidence: This study provides Class IV evidence that in patients with ET treated
with DBS with SID, individualized cs-ILS reduces dysarthria while maintaining tremor control.
Neurology® 2014;82:614–619
GLOSSARY
cs-ILS 5 current-shaping with interleaving stimulation; DBS 5 deep brain stimulation; DDK 5 diadochokinesis; ET 5 essen-
tial tremor; ILS 5 interleaving stimulation; SID 5 stimulation-induced dysarthria; TRS 5 Tremor Rating Scale; TS 5 tremor
suppression; TTD 5 total travel distance; VAS 5 visual analog scale.
Thalamic/subthalamic deep brain stimulation (DBS) is effective in essential tremor (ET), reduc-
ing tremor by 60% to 80%.1 However, stimulation-induced dysarthria (SID) is a common side
effect, affecting approximately 10% of patients.1 In a phonetic study with 15 patients with ET,
we observed an increase of voicing when ventral intermediate nucleus–DBS was activated,
reflecting slurred speech.2 To date, it remains controversial whether stimulation of the target
area itself or current spread affecting neighboring structures causes SID.3 SID and other side
effects occur more often during activation of ventral contacts, especially when high current is
used.3 This leads to the dilemma of choosing suboptimal stimulation parameters (i.e., ampli-
tudes below the SID threshold) to avoid dysarthria at the cost of reduced tremor suppression
(TS). Interleaving stimulation (ILS) describes the possibility of running different stimulation
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programs on the same DBS electrode in a tem-
porally alternating sequence. So far, the neu-
robiological consequences of ILS are unknown.
This new method also allows for individual
current-shaping because different current am-
plitudes can be administered on different con-
tacts, which might help to achieve greater
efficacy and fewer side effects.3 Theoretically,
individualized current-shaping by amplitude
reduction below the SID threshold, together
with activation of a second, more dorsally
located contact with higher stimulation ampli-
tude, might reduce dysarthria while preserving
TS. Three case reports and one case series
(n5 4) suggest better outcomes of DBS during
current-shaped ILS (cs-ILS).4–7 In a recent
study, cs-ILS was used for combined nigral
and subthalamic stimulation, which resulted in
an improvement of freezing of gait in patients
with Parkinson disease compared with subtha-
lamic DBS alone.8 While these studies used cs-
ILS for better DBS outcome, they did not sys-
tematically investigate the effect of current-
shaping. Therefore, there is currently no proof-
of-principle evaluation of current-shaping in
ILS. This systematic, double-blind, exploratory
study compared a regular ILS condition (2 active
contacts with the same current amplitudes) with
a current-shaped condition (cs-ILS, current
shifted to the dorsal contact) regarding TS and
SID. The intention of the present study was not
to show superiority of a stimulation concept (i.
e., ILS) but of the concept of current-shaping for
reduction of SID.
METHODS Standard protocol approvals, ethics, and
patient consents. The study was approved by the local ethics
committee. Patients gave written informed consent before study
participation.
Primary research questions. We hypothesized that current-
shaping reduces dysarthria (superiority: voicing and visual analog
scale [VAS] reduction) without losing the effect on TS
(noninferiority: Tremor Rating Scale [TRS] and kinematic analysis
of postural tremor). The evidence for both research questions is
classified as Class IV because of the absence of a comparison group.
Patients.We screened 26 patients with ETwho had received aDBS
system capable of ILS (ACTIVA RC/PC; Medtronic Inc., Minnea-
polis, MN). Ten of these patients reported a deterioration of speech
postoperatively and 6 (23%) reported an improvement of speech
(at least 10 points on the VAS) when the DBS device was turned
off and were thus included in the study (table; electrode localization
in figure e-1 on the Neurology® Web site at www.neurology.org).
Tremor analysis. Tremor was measured using a movement
analysis system (CMS 20; Zebris Medical GmbH, Isny,
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Germany). Patients performed a postural and a reach-grip task.
The average total travel distance (TTD) was used for
quantification of postural (TTDpostural) and action (TTDaction)
tremor as described previously.9 In addition, patients were
videotaped performing motor parts of the TRS.10 Videos were
rated by J.R., who was blinded for the stimulation condition.
Analysis of dysarthria. Speech was digitally recorded in a
sound-attenuated booth for the following tasks: maximum
phonation time, oral diadochokinesis (DDK), spontaneous
speech, and a read text. Patients rated their “ability to speak”
on a VAS (from 0 [normal] to 100 mm [worst]). Recordings
were assessed independently and blinded by 2 linguists.
Logopedic rating was evaluated with the Frenchay Dysarthria
Score. Phonetic analysis was based on the DDK task as used
previously,2 and the following parameters were measured:
syllable, consonant, vowel, and closure duration; voice-onset
time; friction and voicing during closure; and phonation.
DBS programming algorithm. Patients were tested with stim-
ulation ON and OFF. The electrode inducing SID (determined
by switching off the electrodes separately) was tested on all con-
tacts for TS from 0 to maximum 5 mA in 0.5-mA intervals.
For ILS, the most effective contact was used plus the one dorsal
to it. By increasing the amplitudes in 0.5-mA intervals and
using an instantaneous MATLAB-based (The MathWorks Inc.,
Natick, MA) analysis, we determined the best TS (lowest
TTDpostural). The best cs-ILS was determined by shifting current
Figure 1 Electrode localization of one patient with exemplary tremor and speech parameters
(A) Electrode localization and simulation of the volume of tissue activated was performed with Optivise (Medtronic Inc.)
for the left electrode of patient 3 during interleaving stimulation (ILS) and current-shaping ILS (cs-ILS) conditions. Indi-
vidual anatomical landmarks: the thalamus is shown in magenta, the ventral intermediate nucleus inside the thalamus in
dark blue, the red nucleus in orange, the zona incerta in green, and the subthalamic nucleus in light blue. Note that with
ILS, the 2 pulses are not applied simultaneously to the tissue (as implicated here) but in a temporally alternating
sequence. (B) In this patient, when comparing cs-ILS with ILS, there was an improvement of speech parameters, espe-
cially self-reported overall speech on the visual analog scale (VAS) (in pts [points]), with no deterioration of tremor control
measured with the Tremor Rating Scale (TRS) and kinematic analysis of postural tremor (TTDpostural 5 total travel dis-
tance of postural tremor).
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from the ventral to the dorsal contact in 0.5-mA steps as long as
there was no recurrence of tremor (defined as a 10% increase of the
TTDpostural compared with ILS). We waited at least 5 minutes
between changes of stimulation parameters. The final stimulation
conditions were applied for at least 30 minutes. Stimulation was
performed at frequencies of 125 Hz and pulse widths of 60 ms.
During the ILS/cs-ILS condition, the electrode not responsible for
SID was left in its original settings. Randomization was impossible
because of this predefined programming algorithm.
Statistics. According to our hypotheses, we used 1-sided tests
(paired t test/Wilcoxon signed-rank test) for the ON/OFF
comparison. For the ILS/cs-ILS comparison, we used 1-sided
tests for speech parameters and 2-sided tests for tremor
parameters. According to the exploratory character of this
study, data were not a-corrected for multiple parameters.
RESULTS Electrode location and parameters of an
example patient are shown in figure 1. Overall,
patients had significantly less tremor in the ON con-
dition than in the OFF condition (TRS p 5 0.047,
TTDpostural p 5 0.03, TTDaction p 5 0.046) and a
subjective deterioration of speech in stimulation ON
(VAS p 5 0.031). In line with our previous study,2
the oral DDK rate also deteriorated as shown by the
phonetic parameters of syllable duration (p5 0.021),
vowel duration (p 5 0.026), and consonant duration
(p 5 0.02). Logopedic evaluation showed a trend
toward deterioration of speech in the DDK task dur-
ing DBS ON (p 5 0.063). As expected, when com-
paring ILS and cs-ILS, patients did not show a
difference in TS (TRS p 5 0.50, TTDpostural p 5
0.438, TTDaction p 5 1.0) but a trend toward
subjective improvement of speech during cs-ILS
(4 of 6 patients improved according to the VAS,
Figure 2 Speech parameters in ILS and cs-ILS
(A) Acoustic waveform and spectrogram of one syllable /ka/ during oral diadochokinesis, showing prolonged voicing (marked red) during the stop consonant’s
constriction phase in the stimulation ON condition (C 5 consonant; V 5 vowel; VOT 5 voice onset time). (B) Comparison of voicing during the production of
voiceless stop consonants in interleaving stimulation (ILS) and current-shaping ILS (cs-ILS). Voicing is reduced during cs-ILS (p 5 0.047), reflecting less
dysarthria. (C) Comparison of self-reported overall speech (visual analog scale [VAS] in points [pts]) in ILS and cs-ILS. There is a trend for overall speech
improvement during cs-ILS (p 5 0.094). All diagrams show arithmetic means (61 SD). The asterisk marks a significant difference (p , 0.05).
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p 5 0.094; figure 2). Consistently, phonetic analysis
revealed a reduction of voicing during the production
of voiceless stop consonants (p5 0.047, figure 2) and
also a trend toward an improvement of oral DDK rate
(syllable duration p5 0.056, consonant duration p5
0.08) during cs-ILS, thus reflecting reduced SID.
Logopedic rating showed no difference between ILS
and cs-ILS.
DISCUSSION This is a proof-of-principle study
investigating current-shaping for reduction of SID.
This exploratory study was controlled for various
aspects: first, we controlled for potential neurobiological
effects of ILS per se because both parameter settings
were programmed in an interleaved fashion; second,
we used the same total amount of current and the
same contacts in both conditions, allowing us to
conclude that observed changes are solely attributable
to current-shaping. Furthermore, not only were tremor
and speech parameters analyzed in a blinded manner,
but patients were also unaware of the stimulation
mode. Because ILS and cs-ILS suppressed tremor
equally well, they were indistinguishable by the
patients. Furthermore, we stimulated with constant
current rather than voltage-dependent in order to
compensate unequal impedances of different electrode
contacts. Any inferences that can be drawn from this
study need to be considered in light of the small
number of patients included. However, one has to
bear in mind that only 10% of patients develop SID
and until now there was only a small population of
patients who had been provided with an ILS-capable
device. In summary, the data suggest that current-
shaping, in principle, reduces side effects while
maintaining the beneficial effects of DBS.
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